companiesandmarkets.com

Return to Report | Print

Premium Company Profile - Tanox

http://www.companiesandmarkets.com/Summary-Company-Profile/premium-company-profile-tanox-42819.asp

Report Summary

Introduction

Tanox identifies and develops therapeutic monoclonal antibodies to address significant unmet medical needs in the areas of immunology, infectious diseases and cancer. In January 2007, the stockholders of Tanox approved the merger with Genentech for $20 per share for a total cash value of approximately $919 million

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Highlights

    Tanox is a biopharmaceutical company focused on discovering and developing therapeutic monoclonal antibodies that influence or are derived from the immune system.

    The company's therapeutic emphasis is on the areas of immunology (asthma/allergy and autoimmune diseases), infectious diseases, and oncology.

    Tanox derives its revenues from royalties, license fees, development and manufacturing right, and profit sharing for its humanized monoclonal antibody product, Xolair.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    Overview 1
    Catalyst 1
    Summary 1
    Table of Contents 2
    Table of figures 3
    Table of tables 4
    Company Structure 5
    Company Overview and Key Facts 5
    Business Description 6
    Landmark Products & Services 6
    Xolair 6
    History 7
    M&A History 7
    Genentech 7
    Locations and Subsidiaries 8
    Company Financials 9
    Stock Market Performance 9
    P&L 9
    Balance Sheet 12
    Cash Flow 12
    Business Segment Performance 13
    Products & Services 15
    Marketed Products 15
    Xolair 15
    Pipeline Products 15
    Collaboration Pipeline 15
    TNX 355 16
    TNX 650 16
    TNX 234 16
    TNX 559 16
    AC Forecast Product Sales 17
    Competitors and Strategic Businesss Relationships 19
    Top Competitors 19
    Key Suppliers 19
    Key Clients 20
    Shareholding Structure 21
    Strategy 22
    Corporate Strategy 22
    SWOT Analysis 23
    Overview 23
    Strengths 24
    Xolair 24
    Weaknesses 25
    Weak product pipeline 25
    Opportunities 26
    Merger with Genentech 26
    Growing HIV Market 26
    Threats 27
    Competitive threat 27
    Regulatory challenges 27
    Value Chain Analysis 28
    Overview 28
    Discovery and Product Development 29
    Manufacturing 29
    Scorecard 30
    Overview 30
    Scorecard Analysis 31
    Financial and Operational Overview 32
    Financial and Operational Overview 32
    Appendix 34
    Ask the analyst 34
    Datamonitor consulting 34
    Disclaimer 34
    List of Tables
    Table 1: Tanox - Key Facts 5
    Table 2: Tanox - Other Locations and Subsidiaries 8
    Table 3: Tanox - Year-End Share Price and Market Capitalization, 2002-2006 ($) 9
    Table 4: Tanox - Key Events Impacting Share Price Performance 9
    Table 5: Tanox - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 10
    Table 6: Tanox - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 12
    Table 7: Tanox - Balance Sheet, 2002-2006 ($ Mn) 12
    Table 8: Tanox - Cash Flow, 2002-2006 ($ Mn) 12
    Table 9: Tanox - Revenue Breakdown, 2002-2006 ($ Mn) 13
    Table 10: Tanox - Marketed Products 15
    Table 11: Tanox - Collaboration Pipeline Products 15
    Table 12: Tanox - Forecast Sales, 2006-2010 ($ Mn) 17
    Table 13: Tanox - Top Competitors 19
    Table 14: Tanox - Key Suppliers 20
    Table 15: Tanox - Key Clients 20
    Table 16: Tanox - Key Shareholders 21
    Table 17: Tanox - SWOT Analysis Summary 23
    Table 18: Tanox - Value Chain Analysis 28
    Table 19: Tanox - Scorecard 30
    Table 20: Tanox - Financial and Operational Overview 32
    List of Figures
    Figure 1: Tanox - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 11
    Figure 2: Tanox - Key Strategic Revenues, 2002-2006 ($ Mn) 14
    Figure 3: Tanox - Key Strategic Revenues, 2006-2010 ($ Mn) 18